Liu Benye, Falkenstein-Paul Hildegard, Schmidt Werner, Beerhues Ludger
Institut für Pharmazeutische Biologie, Mendelssohnstrasse 1, D-38106 Braunschweig, Germany.
Plant J. 2003 Jun;34(6):847-55. doi: 10.1046/j.1365-313x.2003.01771.x.
Benzophenone derivatives, such as polyprenylated benzoylphloroglucinols and xanthones, are biologically active secondary metabolites. The formation of their C13 skeleton is catalyzed by benzophenone synthase (BPS; EC 2.3.1.151) that has been cloned from cell cultures of Hypericum androsaemum. BPS is a novel member of the superfamily of plant polyketide synthases (PKSs), also termed type III PKSs, with 53-63% amino acid sequence identity. Heterologously expressed BPS was a homodimer with a subunit molecular mass of 42.8 kDa. Its preferred starter substrate was benzoyl-CoA that was stepwise condensed with three malonyl-CoAs to give 2,4,6-trihydroxybenzophenone. BPS did not accept activated cinnamic acids as starter molecules. In contrast, recombinant chalcone synthase (CHS; EC 2.3.1.74) from the same cell cultures preferentially used 4-coumaroyl-CoA and also converted CoA esters of benzoic acids. The enzyme shared 60.1% amino acid sequence identity with BPS. In a phylogenetic tree, the two PKSs occurred in different clusters. One cluster was formed by CHSs including the one from H. androsaemum. BPS grouped together with the PKSs that functionally differ from CHS. Site-directed mutagenesis of amino acids shaping the initiation/elongation cavity of CHS yielded a triple mutant (L263M/F265Y/S338G) that preferred benzoyl-CoA over 4-coumaroyl-CoA.
二苯甲酮衍生物,如多异戊烯基化苯甲酰基间苯三酚和呫吨酮,是具有生物活性的次生代谢产物。它们C13骨架的形成由二苯甲酮合酶(BPS;EC 2.3.1.151)催化,该酶已从金丝桃的细胞培养物中克隆得到。BPS是植物聚酮合酶(PKSs)超家族的一个新成员,也被称为III型PKSs,氨基酸序列同一性为53 - 63%。异源表达的BPS是一种同源二聚体,亚基分子量为42.8 kDa。其优选的起始底物是苯甲酰辅酶A,它与三个丙二酰辅酶A逐步缩合生成2,4,6 - 三羟基二苯甲酮。BPS不接受活化的肉桂酸作为起始分子。相比之下,来自相同细胞培养物的重组查尔酮合酶(CHS;EC 2.3.1.74)优先使用4 - 香豆酰辅酶A,并且也能转化苯甲酸的辅酶A酯。该酶与BPS的氨基酸序列同一性为60.1%。在系统发育树中,这两种PKSs出现在不同的簇中。一个簇由包括来自金丝桃的CHS在内的CHSs组成。BPS与功能不同于CHS的PKSs聚集在一起。对塑造CHS起始/延伸腔的氨基酸进行定点诱变产生了一个三重突变体(L263M/F265Y/S338G),该突变体优先选择苯甲酰辅酶A而非4 - 香豆酰辅酶A。